Monday, September 14, 2026

K-Pop Label JYP Entertainment Supports Vulnerable Children with Massive Donation

JYP Entertainment has signed an agreement with...

Korean Firms Accelerate U.S. Rare Earth Push to Cut Reliance on China

South Korean firms are establishing rare earth production hubs in the U.S. to reduce reliance on China, supported by government funding.

Trump Under Fire for Using Presidential Seal at Crypto Investor Dinner

Trump faces legal scrutiny for using the presidential seal at a dinner for Trump Token investors, raising concerns over foreign involvement.

Tag: Keytruda

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Celltrion’s CT-P51: Will This Keytruda Biosimilar Disrupt the 44 Billion USD Cancer Drug Market?

Celltrion has applied for approval of its biosimilar CT-P51 for the global blockbuster immuno-oncology drug Keytruda (pembrolizumab).

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

How Keytruda is Revolutionizing Cancer Treatment: Expanded Coverage for Stomach Cancer in 2026

Keytruda's insurance coverage expands to stomach cancer, solidifying its status as a leading universal immunotherapy for various cancers.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.